Indian stocks: Visit www.stage2stocks.com →

Firefly Neuroscience, Inc.

Stage 1 · Basing · week 4

As of Oct 22, 2026, Firefly Neuroscience is in Stage 1, the basing phase, now in week 4 (since Sep 30, 2026). It closed at $1.02, 66.2% below its 52-week high and below its 200-day average, which is falling.

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the compl… More about the company

$1.02
-0.99% today
$16.0M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Steady

Edge

—

Is AIFF early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 23w
S4 28w
S4 46w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 1w → S1 5w → S4 23w → S1 9w → S2 5w → S3 7w → S4 28w → S1 5w → S2 5w → S3 1w → S4 46w → S1 7w → S2 4w → S3 4w → S4 12w → S1 3w current
Total tracked: 165 weeks across 16 stage runs.

AIFF among Software - Application156th of 221 by relative strength

All 221 →
Stocks in Software - Application ranked by relative strength, with stage and one-month change
#StockStageRS1M
1RNGStage 2 · wk 1397+0.2%
2DHXStage 2 · wk 2997+3.5%
3FSLYStage 2 · wk 1197−24.3%
4PUBMStage 2 · wk 2495−1.6%
5FROGStage 2 · wk 2194+1.7%
6MITKStage 3 · wk 593+1.0%
7RSKDStage 2 · wk 1993+24.9%
8OOMAStage 3 · wk 192−10.7%
…156AIFFStage 1 · wk 420−11.3%
vs 52W High
-66.2%
$0.64 lo$3.02 hi
66.2% below 52W high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 4
1w13w26w
Week 4, early base
How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.
vs 200 DMA
-25.6%
200 DMA: $1.37 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.02x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-11.3%
3M
-8.1%
6M
-50.5%
YTD
+14.6%
1Y
-56.6%
Scan Membership
Breakout Watch
Latest: 2025-03-17
5 appearances in last 60 days. First seen: 2020-06-11.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S1
Wk 4 · Vol 0.02x
2026-10-21S1
Wk 4 · Vol 0.01x
2026-10-20S1
Wk 3 · Vol 0.02x
2026-10-19S1
Wk 3 · Vol 0.02x
2026-10-16S1
Wk 3 · Vol 0.04x
2026-10-15S1
Wk 3 · Vol 0.03x
2026-10-14S1
Wk 3 · Vol 0.05x
2026-10-13S1
Wk 2 · Vol 0.04x
2026-10-12S1
Wk 2 · Vol 0.04x
2026-10-09S1
Wk 2 · Vol 0.03x
2026-10-08S1
Wk 2 · Vol 0.08x
2026-10-07S1
Wk 2 · Vol 0.08x
Moving averages & range
50 DMA
$1.17
200 DMA
$1.37
52W High
$3.02
52W Low
$0.64
5D Low
$1.00
Resistance levels (recent highs)
20d High
$2.01
60d High
$2.01
120d High
$2.16
250d High
$3.02
Next resistance
+97.1%
to 20d High
ROE
-68.1%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 1.1

Firefly Neuroscience: quick answers

What stage is Firefly Neuroscience in?

As of Oct 22, 2026, Firefly Neuroscience (AIFF) is in Stage 1, the basing phase. It entered Stage 1 on Sep 30, 2026 and is in week 4. What the four stages mean

Is Firefly Neuroscience in an uptrend?

Not yet. Firefly Neuroscience is in Stage 1, a base that can come before an uptrend. It trades 25.6% below its 200-day average, which is falling.

How far is Firefly Neuroscience from its 52-week high?

Firefly Neuroscience closed at $1.02 on Oct 22, 2026, 66.2% below its 52-week high of $3.02. Its 52-week low is $0.64.

How has Firefly Neuroscience performed over the past year?

As of Oct 22, 2026, Firefly Neuroscience is down 56.6% over the past year and up 14.6% so far in 2026.

Which sector and industry is Firefly Neuroscience in?

Firefly Neuroscience is in the Software - Application industry, part of the Information Technology sector.

About this companyInformation Technology· Software - Application

Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. It serves clinicians. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.